Peter recently joined the Westwicke team after spending nearly 10 years as an investor relations officer with life sciences companies and close to a decade as a sell-side research analyst.
Prior to joining Westwicke, Peter spent six years as Director or Senior Director of Investor Relations with two biotechnology companies, MedImmune and Human Genome Sciences. He worked most recently as Director, Global Investor Relations with Qiagen, a life sciences company based in Germany. Peter has also previously worked as Vice President, Investor Relations at Catalyst Health Solutions, a pharmacy benefit manager.
Peter started his Wall Street career as a sell-side analyst, working as an equity research analyst with Unterberg Harris in New York, a Senior Equity Securities Analyst with Interstate/Johnson Lane and [as what] at Wachovia Services in Charlotte, North Carolina.
Peter earned a BS in Chemistry and an MBA in Finance/Accounting, both from the University of Connecticut.